Trending
- Accretion Pharma IPO Opens: Worth the Bet?
- India Asserts Tech Independence with 6th Semiconductor Plant
- The Coincidence of May 14: A Tale of Two Dividend Announcements
- India-Russia 2030: Setting the Stage for the Next Trade Boom
- The Vanishing Oil: Why India’s Palm Imports Plunged in April
- India’s Trade with Turkey, Azerbaijan Faces Strain Over Pakistan Stance
- Addepar, the $7T WealthTech Giant, Powers Global Expansion with $230M
- Building the Future of Global Investments: iCapital and Citi Wealth’s Powerful Alliance
IPO
On May 14, Accretion Pharmaceuticals Limited, a Gujarat-based pharmaceutical manufacturer, opened its ₹29.75 crore IPO, receiving a 49% overall subscription by mid-day. With a…
India’s IPO landscape is witnessing a slowdown as global economic concerns and geopolitical tensions take…
The Arunaya Organics IPO allotment is set to be finalized today, May 5, 2025. Investors…
Jinkushal Industries Ltd (JKIPL) has submitted its initial public offering (IPO) papers to the Securities…
Oyo, the Indian budget hotel aggregator, has delayed its IPO attempt for the third time,…
India-based electric vehicle manufacturer Ather Energy, headquartered in Karnataka, recently concluded its IPO subscription phase…
Corona Remedies, a pharmaceutical company headquartered in Ahmedabad, has filed draft papers with the Securities…
Advertisement
